Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

This Week's Healthcare Earnings: UnitedHealth, HCA, J&J No Photo Available

Yeji Jesse Lee

It was a week of good news and bad news for the healthcare industry. Earnings season kicked off when three companies posted financials... (more story)

Texas AG's Vaccine Probe Draws Fire From Health Experts No Photo Available

Hannah Albarazi

Public health experts are condemning a Texas Attorney General inquiry into Pfizer, UnitedHealth Group and others for allegedly tapping... (more story)

Biotech Fundraising A Good Sign For Public Markets No Photo Available

Yeji Jesse Lee

At the start of what many healthcare attorneys hope will be a busy year, public biotechs are raising cash, signaling a thawing public ... (more story)